Inflammation markers, such as Gal-3, as well as CMR sequences for T1 mapping or ECV quantification, are not included in MI diagnosis and treatment protocols in the corresponding clinical practice guidelines, so larger studies are needed to confirm the role of these markers and imaging parameters in the diagnosis, treatment, and prognosis of MI. Here, LGALS3 is linked to myocardial infarction.